Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy for cutaneous squamous cell carcinoma in situ and superficial basal cell carcinoma
ChiCTR-ONC-13003625Phase 4Completed
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of 5-aminolevulinic acid in Bowen disease (BD) and basal cell carcinoma (BCC), sponsored by Institute of Dermatology, Chinese Academy of Medical Sciences. Primary endpoints: Regression of lesion, Recurrence rate and 3 more. Started Oct 2013; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
Bowen disease (BD)basal cell carcinoma (BCC)
Beyond the preview
Go deeper on ChiCTR-ONC-13003625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003625.